HA
PRAX icon

Homestead Advisers’s Praxis Precision Medicines PRAX Stock Holding History

Homestead Advisers’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.18M Buy
6,500
+3,200
+97% +$1.01M 0.05% 99
2026
Q1 		$1.06M Buy
+3,300
New +$1.02M 0.03% 108

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Homestead Advisers's PRAX Position: Q2 2026 in Review

Homestead Advisers increased its Praxis Precision Medicines (PRAX) stake by 97% in Q2 2026, buying an estimated $1.01M and bringing the position to 6,500 shares worth $2.18M. The position accounts for 0.05% of the portfolio, ranked #99.

Homestead Advisers first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Homestead Advisers held 6,500 shares of Praxis Precision Medicines worth $2.18M as of Q2 2026.
  • Homestead Advisers bought 3,200 Praxis Precision Medicines shares in Q2 2026, an estimated $1.01M.
  • Praxis Precision Medicines made up 0.05% of Homestead Advisers's portfolio in Q2 2026, its #99 holding.
  • Homestead Advisers first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Homestead Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.